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Background. The expression term of the gene transfected in cells needs to belong enough inorder to make a gene therapy clinically
effective.The controlled release of the transfected gene can be utilized.Thenewbiodegradable hydrogelmaterial created by 20 w/w%
aldehyded dextran and 10w/w% 𝜀-poly(L-lysine) (ald-dex/PLL) was developed. We examined whether it could be as a nonviral
carrier of the gene transfer.Methods. A plasmid (Lac-Z) was mixed with ald-dex/PLL. An in vitro study was performed to assess the
expression of Lac-Z with X-gal stain after gene transfer into the cultured 293 cells and bone marrow cells. As a control group, PLL
was used as a cationic polymer. Results. We confirmed that the transfection efficiency of the ald-dex/PLL had a higher transfection
efficiency than PLL in 293 cells (plasmid of 2𝜇g: ald-dex/PLL 1.1%, PLL 0.23%, plasmid of 16 𝜇g: ald-dex/PLL 1.23%, PLL 0.48%).
In bone marrow cells, we confirmed the expression of Lac-Z by changing the quantity of aldehyded dextran. In the groups using
ald-dextran of the quantity of 1/4 and 1/12 of PLL, their transfection efficiency was 0.43% and 0.41%, respectively. Conclusions. This
study suggested a potential of using ald-dex/PLL as a non-carrier for gene transfer.
1. Introduction
Recently, many studies about gene therapy have been pub-
lished. One of the achievements in gene therapy is safe and
effective expression of the gene in the body. The naked DNA
is the safe but rapidly degraded by nucleases, and it shows a
poor cellular uptake. Success of gene therapy largely relies on
gene delivery vectors [1, 2]. Although viral vectors have good
transfer efficiency, the consequent immunogenic side effect is
not negligible. On the other hand, advantages of safe nonviral
carriers include an ability to introduceDNA into nondividing
cells, avoidability of integration into the chromosome, lack
of infective risks, and an expense potentially lower cost
than viral vectors. However, nonviral carriers display poorer
transfer efficiency than viral vectors [3]. Therefore, nonviral
gene carriers such as cationic polymer [4], cationic lipid [5],
and polysaccharide [6] have been developed to improve this
weak point [1].
A cationic polymer and lipid form complexes with
DNA by electrostatic interactions between positively charged
amine of the polycations and negatively charged phosphate
groups of the DNA. This can condense DNA into a relatively
small size via ionic interactions, which is important for gene
transfer because a small size is favorable for cellular uptake
[4, 7]. In addition, the interaction between the complexes
and negatively charged cell membranes can enhance DNA
uptake by the cells [3].These help to increase the transfection
efficiency.
Recently, a wide range of materials has been investigated
as a delivery vector of plasmid DNA. In the cationic polymer,
poly(L-lysine) (PLL) is a well-known nonviral gene carrier
that is biodegradable and nonantigenic. Nevertheless, it is
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Figure 1: The chemical structure and cross-linking of the new biodegradable hydrogel composed of aldehyded dextran/PLL and plasmid
DNA. After the mixture of the solution, gel formation proceeds on the basis of Schiff base formation. Plasmid DNA interacts with PLL by
electrostatic interactions between positively charged amine of the PLL and negatively charged phosphate groups of the plasmid DNA.
toxic and tends to bind nonspecifically to the surface of all
mammalian cells [8]. Therefore, it is relevant to modify PLL
in order to be a safe and effective nonviral gene carrier [9].
Furthermore, the expression term of the gene transfected in a
cell needs to be long enough in order to make a gene therapy
clinically effective. The technique of controlled release of the
transfected gene is utilized to lengthen the expression term
by controlling the expression level and the term of gene.
Until now, various controlled release techniques of gene have
been reported [10–13]. Recently, a novel self-biodegradable
bioadhesive hydrogelmaterial has been developed. It was cre-
ated by mixing aldehyded dextran and 𝜀-PLL (ald-dex/PLL).
A gel is formed after the mixture, which can control the
degradation speed by changing the concentrations of acetic
anhydride in PLL [14]. These characteristics are useful for
controlled release of gene, since PLL can combine with
DNA.
Of further note, mesenchymal stem cells (MSCs) have a
high potential of proliferation and differentiation.The growth
factors stimulating and inducing MSCs differentiation are
indispensable for MSCs to differentiate into the desired cells
[15]. Establishment of a gene transfer technique for MSCs
enhances gene therapy and tissue engineering using MSCs
[16]. In this study, we used the ald-dex/PLL to transfer the
gene into MSCs and examined whether it can be used as a
nonviral gene carrier of the gene transfer in vitro.
2. Materials and Methods
As a nonviral carrier of gene transfer, 10 w/w% PLL (Mw =
4,000) which contained 2w/w% acetic anhydride and
20w/w% ald-dex (Mw = 75KDa) which was prepared by
introducing the aldehyde group into dextran with an oxidizer
were used.
A plasmid DNA named pCAGGS-lacZ which causes the
cytoplasmic expression of E. coli 𝛽-galactosidase was used.
The plasmid vectors were grown in Escherichia coli DH5
𝛼 and prepared with a Qiagen Plasmid Giga Kit (Qiagen
GmbH, Hilden, Germany) according to the manufacturer’s
instructions. To verify the identity and purity of the plasmid
vectors, agarose gel electrophoresis was performed after
restriction endonuclease digestion. The plasmid DNA con-
centration was determined using a UV/visible spectropho-
tometer (DU-530, Beckman, Fullerton, CA, USA).
To assess the effect of transfection on mammalian cells,
293 cells obtained from the RIKEN Cell Bank (Tsukuba,
Japan) and normal rat bone marrow cells obtained from the
TAKARA BIO Japan were used. The cells were maintained
in DMEM containing 5% fetal bovine serum (FBS) and
penicillin as well as streptomycin (PS). Cell cultures were
grown at 37∘C in a humidified atmosphere of 95% air and 5%
CO
2
. Upon confluence, 1.4 × 105 cells per well were reseeded
into 12 well plates and incubated for 24 hours.
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Figure 2: Gene transfection into 293 cells. (a), (b), and (c): results of gene transfection in plasmid of 2 𝜇g. (d), (e), and (f): results of gene
transfection in plasmid of 16𝜇g. (a) and (d) were carried out by only plasmid, and (b) and (e) were carried out by using PLL as a gene carrier,
for the purpose of controls. (c) and (f) were carried out by using ald-dex/PLL as a gene carrier.
The cases included 293 cells using the same amount of
ald-dex and PLLmixed with plasmid DNA in DMEM, whilst
the controls used only PLL with plasmid DNA in DMEM.
The concentrations of plasmid DNA were 2 𝜇g and 16 𝜇g,
respectively. Both were incubated at 25∘C overnight. In the
cultures of bone marrow cells, ald-dex of the amount of
1/1, 1/4, and 1/12 of PLL and PLL were mixed with plasmid
DNA (concentration: 2 𝜇g) in DMEM and incubated at 25∘C
overnight.
After the cells were about 80% confluent, themediumwas
changed to DMEM supplemented with PS without FBS. The
solution of the complexes was applied and incubated at 37∘C
in a humidified atmosphere of 95% air and 5% CO
2
for 24
hours. In the cultures of 293 cells, only plasmids were applied
as the controls. After 24 hours’ transfection, the medium was
changed to a new medium containing FBS. After another 24
hours, X-gal stain was performed to examine the transfection
efficiency. The cells were fixed for 5 minutes in phosphate-
buffered saline (PBS) containing 2% formaldehyde and 0.2%
glutaraldehyde at the room temperature. They were subse-
quently washed with PBS and stained for 2 hours at 37∘C in a
5-bromo-4-chloro-3-indolyl-𝛽-D-galactopyranoside (X-gal)
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Figure 3: Gene transfection into MSCs. (a) Transfection with ald-dex (1/1 of PLL) and PLL. (b) Transfection with ald-dex (1/4 of PLL) and
PLL. (c) Transfection with ald-dex (1/12 of PLL) and PLL.
staining solution containing 1mg/mL X-gal, 2mM MgCl2,
5mM,K3Fe (CN)6, and 5mMK4Fe (CN)6⋅3H2O inPBS (pH
7.4). The experiments were repeated three times except the
experiments using only PLL, which were repeated four times.
3. Results and Discussion
Ald-dex/PLL hydrogel was formed by Schiff base formation
between oxidized and aldehyded dextran and PLL [14].
The chemical structure and cross-linking are displayed in
Figure 1. PLL has a sufficient number of primary amines
with positive charges to interact with negatively charged
phosphate groups of DNA. PLL/DNA complexes have a
higher tendency to form precipitates [1, 17]. Previous studies
reported that PLL has modified hydrophilic dextran with
a reductive amination reaction between amino groups of
PLL and reductive ends of dextran in order to increase the
solubility of PLL/DNA complexes in aqueous media. The
dextran chains do not disturb the electrostatic interaction
between PLL and DNA [17]. The schema of ald-dex/PLL and
plasmid DNA complex is shown in Figure 1. The complexes
interact with negatively charged cell membranes and are
taken into cells via endocytosis [1].
In the 293 cells, on the second day after lacZ gene transfer,
we found that X-gal positive cells were present in all receiving
transfections expect only plasmid transfection (Figure 2). In
the groups with 2𝜇g plasmids, transfection efficiency of PLL
and ald-dex/PLL reached to 0.24 ± 0.17% and 1.10 ± 0.25%,
respectively (𝑃 < 0.05 versus PLL). In the groups with 16 𝜇g
plasmids, transfection efficiency of PLL and ald-dex/PLL
reached to 0.48 ± 0.27% and 1.23 ± 1.16%, separately (𝑃 >
0.05). These demonstrated that ald-dex/PLL hydrogel could
be used as a gene carrier. A higher transfection efficiency
could be achieved by using ald-dex/PLL comparedwith using
only PLL.
Subsequently, we performed the gene transfer to MSCs
existing in bone marrow cells. In the bone marrow cells, X-
gal positive cells were not seen in the group using the same
amount of ald-dex and PLL, whilst the specific cells were
present in other groups (Figure 3). Transfection efficiency
of the groups using ald-dex of 1/4 and 1/12 of PLL reached
0.43 ± 0.11% and 0.41 ± 0.09, respectively (𝑃 > 0.05). This
study demonstrated the feasibility of transferring a gene into
MSCs by decreasing the amount of ald-dex in ald-dex/PLL.
An earlier study has suggested that the degree of grafting and
length of graft chains had an influence on physicochemical
properties of DNA in a complex. PLL-graft-dextran copoly-
mers having a lower degree of grafting or shorter dextran
chains could interact firmly with the DNAs and condense
DNA [17]. This agreed with our findings. Furthermore, it
has been reported that the PLL graft copolymers showing
cell specific polysaccharide chains could perform cell specific
delivery and express a foreign gene in vivo [18]. This study
found different results between 293 cells andMSCs, since the
uptake of complexes into cell is related to the cell specificity.
The novel self-biodegradable bioadhesive hydrogel, ald-
dex/PLL, which could be degraded by hydrolysis in the body
was developed. The favorable characteristics of ald-dex/PLL
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included a high bonding strength, a high flexibility, and
a low cytotoxicity. Moreover, the onset time of hydrogel
formation can be controlled by changing the amount of
aldehyde introduced into dextran. The in vitro degradation
speed of hydrogel can also be controlled by changing acetic
anhydride concentration in the PLL solution [14].
A purpose of regeneration therapy is to induce the repair
of defective tissues based on the natural healing potential in
patients. It is desirable to use growth factors and/or genes
to enhance cell proliferation and differentiation. The release
technique is indispensable to make this possible. The success
of controlled release of growth factors and genes relies on
the incorporation of the growth factors and/or genes with
appropriate carriers. Upon appropriate incorporation with
carriers, the growth factors and/or genes are protected against
proteolysis in the body, and consequently the active time can
be lengthened [19].
This study has confirmed the feasibility of gene delivery
using a novel self-biodegradable hydrogel. The ald-dex/PLL
hydrogel showed a possibility to be used as a nonviral carrier
for controlled release. Clinically, ald-dex/PLL combining
plasmid DNA could be applied to the injured tissue to
enhance tissue healing and regeneration. Thus, ald-dex/PLL
combining BMP-2 encoding plasmids can be applied to a
defect to enhance bone regeneration in case of fractures of
a bone. Moreover, ald-dex/PLL hydrogel has been used as a
surgical sealant [20]. If ald-dex/PLL combining with growth
factor or genes is used as a surgical sealant, curing wounds
with the new technique will become effective and feasible.
4. Conclusion
Our results suggest the potential of gene therapy using ald-
dex/PLL hydrogel as a nonviral carrier. Furthermore, self-
biodegradability and control of degradation speed in the
ald-dex/PLL hydrogel indicated future applications in release
technology.
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